Caren Deardorf Crinetics Pharmaceuticals, Inc. (CRNX) insider trading activity

CRNX Quotes by TradingView

Caren Deardorf is of Crinetics Pharmaceuticals, Inc.. Currently has a direct ownership of 16,300 shares of CRNX, which is worth approximately $526,979. The most recent transaction as insider was on Jun 11, 2025, when has been sold 6,900 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 16.3K
73.4% 3M change
73.4% 12M change
Total Value Held $526,979

Caren Deardorf Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 11 2025
BUY
Grant, award, or other acquisition
-
6,900 Added 29.74%
16,300 Common Stock
Jun 07 2024
BUY
Grant, award, or other acquisition
-
3,400 Added 26.56%
9,400 Common Stock
Jun 16 2023
BUY
Grant, award, or other acquisition
-
6,000 Added 50.0%
6,000 Common Stock

Also insider at

MGTA
Magenta Therapeutics, Inc. Healthcare
Chief Commercial Officer
CD

Caren Deardorf

San Diego, CA

Track Institutional and Insider Activities on CRNX

Follow Crinetics Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRNX shares.

Notify only if

Insider Trading

Get notified when an Crinetics Pharmaceuticals, Inc. insider buys or sells CRNX shares.

Notify only if

News

Receive news related to Crinetics Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CRNX